PPAR Research

PPARs and Anticancer Therapies


Publishing date
01 Jan 2010
Status
Published
Submission deadline
01 Jul 2009


PPARs and Anticancer Therapies

Description

Over the past five years, published issues of PPAR Research have covered a broad expanse of physiological functions and clinical importance of PPARs. Topics spanned reviews of PPARs function in specific cell and tissue types, their roles in a host of diseases, and their rich pharmaceutical potential. Yet, no issue so far has been dedicated to the role of PPARs in parasitic infections. Clearly, the immunomodulatory capacity of PPARs can be influential in the delicate balance between host defense and parasite survival.

Accordingly, this issue will focus on different aspects of PPARs in relationship to protozoan and metazoan parasites: biology, immunology, pathology, and therapy.

We invite authors to present original research articles or reviews that address any aspect of the role of PPARs and parasitic diseases. Potential topics include, but are not limited to:

  • PPAR expression during infections by parasitic protozoans and helminthes
  • Intracellular survival of pathogens in relation to PPAR status
  • PPAR protection and elimination of parasites
  • Lipid mediators and their modulation of antiparasitic immune response
  • PPAR ligands and parasitic diseases

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/ppar/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/ according to the following timetable:


Articles

  • Special Issue
  • - Volume 2010
  • - Article ID 536415
  • - Editorial

PPARs and Anticancer Therapies

Michael E. C. Robbins | Christine Linard | Dipak Panigrahy
  • Special Issue
  • - Volume 2010
  • - Article ID 427401
  • - Review Article

PPARs in Human Neuroepithelial Tumors: PPAR Ligands as Anticancer Therapies for the Most Common Human Neuroepithelial Tumors

Elisabetta Benedetti | Renato Galzio | ... | Annamaria Cimini
  • Special Issue
  • - Volume 2010
  • - Article ID 814609
  • - Review Article

Anticancer Role of PPAR Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes

P. J. Simpson-Haidaris | S. J. Pollock | ... | R. P. Phipps
  • Special Issue
  • - Volume 2010
  • - Article ID 956427
  • - Review Article

Therapeutic Implications of PPAR in Human Osteosarcoma

Eric R. Wagner | Bai-Cheng He | ... | Rex C. Haydon
  • Special Issue
  • - Volume 2010
  • - Article ID 528327
  • - Review Article

PPARs in Irradiation-Induced Gastrointestinal Toxicity

Christine Linard | Maâmar Souidi
  • Special Issue
  • - Volume 2010
  • - Article ID 729876
  • - Research Article

Combination PPAR and RXR Agonist Treatment in Melanoma Cells: Functional Importance of S100A2

Joshua P. Klopper | Vibha Sharma | ... | Bryan R. Haugen
  • Special Issue
  • - Volume 2010
  • - Article ID 234975
  • - Review Article

Role of PPARs in Radiation-Induced Brain Injury

Sriram Ramanan | Weiling Zhao | ... | Mike E. Robbins
  • Special Issue
  • - Volume 2010
  • - Article ID 848645
  • - Research Article

Cyclooxygenase 2 (COX2) and Peroxisome Proliferator-Activated Receptor Gamma (PPARG) Are Stage-Dependent Prognostic Markers of Malignant Melanoma

Stefanie Meyer | Thomas Vogt | ... | Peter J. Wild
PPAR Research
 Journal metrics
See full report
Acceptance rate11%
Submission to final decision75 days
Acceptance to publication21 days
CiteScore5.800
Journal Citation Indicator0.720
Impact Factor2.9
 Submit Evaluate your manuscript with the free Manuscript Language Checker

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.